| 1110 |
decreased |
cellular response to oxidative stress
(GO:0034599)
|
|
1869: Diminished protective oxidative stress response
|
| 714 |
increased |
cellular response to oxidative stress
(GO:0034599)
|
|
1394: Induction, persistent proliferation/sustained proliferation
|
| 788 |
decreased |
cellular response to type I interferon
(GO:0071357)
|
type I interferon receptor complex
(GO:0038197)
|
None
|
| 708 |
abnormal |
chemical synaptic transmission
(GO:0007268)
|
synapse
(GO:0045202)
|
758: Hippocampal Physiology, Altered
|
| 44 |
abnormal |
chemical synaptic transmission
(GO:0007268)
|
|
None
|
| 51 |
decreased |
chemical synaptic transmission
(GO:0007268)
|
|
669: Reduction, Neuronal synaptic inhibition
|
| 195 |
increased |
chemokine activity
(GO:0008009)
|
Chemokine
(FMA:241981)
|
151: Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways
|
| 854 |
increased |
chemokine secretion
(GO:0090195)
|
Chemokine
(FMA:241981)
|
1496: Increased, secretion of proinflammatory mediators
|
| 14 |
increased |
chitin biosynthetic process
(GO:0006031)
|
chitin
(CHEBI:17029)
|
990: Increase, Incomplete ecdysis
|
| 751 |
decreased |
chitin synthase activity
(GO:0004100)
|
|
1522: Inhibition, Chitin synthase 1
|
| 791 |
decreased |
chloride channel activity
(GO:0005254)
|
|
1906: Cystic Fibrosis Transmembrane Regulator Function, Decreased
|
| 397 |
increased |
chloride channel activity
(GO:0005254)
|
glutamate-gated chloride channel (fruit fly)
(PR:Q94900)
|
2 Events
|
| 399 |
increased |
chloride transmembrane transport
(GO:1902476)
|
chloride
(CHEBI:17996)
|
761: Increased, Chloride conductance
|
| 280 |
decreased |
cholesterol biosynthetic process
(GO:0006695)
|
cholesterol
(CHEBI:16113)
|
2 Events
|
| 1026 |
increased |
cholesterol biosynthetic process
(GO:0006695)
|
|
2270: Increased, cholesterol synthesis enzymes
|
| 734 |
decreased |
cholesterol transport
(GO:0030301)
|
cholesterol
(CHEBI:16113)
|
807: Decreased, cholesterol
|
| 735 |
decreased |
cholesterol transport
(GO:0030301)
|
cholesteryl ester
(CHEBI:17002)
|
807: Decreased, cholesterol
|
| 863 |
increased |
chromosomal instability
(MP:0008866)
|
chromosome
(GO:0005694)
|
2 Events
|
| 862 |
increased |
chromosome breakage
(GO:0031052)
|
chromosome
(GO:0005694)
|
2 Events
|
| 371 |
abnormal |
chromosome movement towards spindle pole
(GO:0051305)
|
chromosome
(GO:0005694)
|
752: Altered, Meiotic chromosome dynamics
|
| 357 |
abnormal |
chromosome segregation
(GO:0007059)
|
|
696: Increased, Chromosome misseggregation
|
| 826 |
increased |
chronic inflammatory response
(GO:0002544)
|
|
1868: Hyperinflammation
|
| 944 |
occurrence |
clathrin-dependent endocytosis
(GO:0072583)
|
|
None
|
| 894 |
increased |
Cleft palate
(HP:0000175)
|
|
2042: Increase, Orofacial clefting
|
| 895 |
increased |
cleft upper lip
(MP:0005170)
|
|
2042: Increase, Orofacial clefting
|